AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18230250
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination drugs (FDCs)
Trial: 18230250
Drug: Loose drugs
RxNorm normalized name: Goose
DrugBank: Goose (DB10874)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loose drugs
Trial: 2484663
Drug: Pirbuterol 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirbuterol 0.4 mg
Trial: 1346562
Drug: Pirbuterol 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirbuterol 0.8 mg
Trial: 1346562
Drug: Pirbuterol 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirbuterol 1.2 mg
Trial: 6437131
Drug: Tocainide HCl
RxNorm normalized name: tocainide HCl
DrugBank: Tocainide (DB01056)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tocainide HCl (900 mg daily)
Trial: 24488498
Drug: Low-dose enteric-coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose enteric-coated aspirin tablets (100 mg/day for 2 years)
Trial: 20179259
Drug: Pitavastatin 1
RxNorm normalized name: PITAVASTATIN 1MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 1 mg once daily
Trial: 15675981
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no rHuEPO therapy)
Trial: 2266990
Drug: Mazindol (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazindol (3 mg/d)
Trial: 6106828
Drug: sulphinpyrazone (SPZ)
RxNorm normalized name: Sulphinpyrazone
DrugBank: Sulfinpyrazone (DB01138)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sulphinpyrazone (SPZ) 200 mg orally
Trial: 28317828
Drug: magnetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: magnetic therapy for 5 min №10 in maxillary and mandibular areas
Trial: 16330466
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ramipril 5 mg/day + candesartan 8 mg/day)
Trial: 16330466
Drug: Ramipril alone
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramipril alone (10 mg/day)
Trial: 16330466
Drug: Candesartan alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan alone (16 mg/day)
Trial: 8225636
Drug: Clarithromycin 250
RxNorm normalized name: clarithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 250 mg b.i.d. for 5 days
Trial: 8225636
Drug: Clarithromycin 250
RxNorm normalized name: clarithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 250 mg b.i.d. for 10 days
Trial: 3081928
Drug: Oxazepam 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam 1.2 mg/kg
Trial: 30230257
Drug: Old drug
RxNorm normalized name: Oldenlandia diffusa extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Old drug product (DP)
Trial: 30230257
Drug: New drug
RxNorm normalized name: varicella zoster immune globulin (Investigational New Drug)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drug product (DP)
Trial: 30230257
Drug: Upper arm
RxNorm normalized name: A And D Medical UA-651 Upper Arm BPM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upper arm injection site
Trial: 30230257
Drug: Thigh injection
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thigh injection site
Trial: 30230257
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of emicizumab
Trial: 25004335
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg oral estradiol per day
Trial: 25004335
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg venlafaxine per day
Trial: 19826112
Drug: 31 oncology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 31 oncology drugs approved without a randomized trial
Trial: 19826112
Drug: Gefitinib (EGFR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib (EGFR inhibitor)
Trial: 19826112
Drug: 31 oncology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 31 oncology drugs
Trial: 19826112
Drug: 19 of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 19 of the 31 drugs
Trial: 12690666
Drug: Dopaminergic agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic agonists
Trial: 12690666
Drug: Catechol‐O‐methyl transferase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catechol‐O‐methyl transferase inhibitors
Trial: 9522658
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) 1 g/kg
Trial: 9522658
Drug: Methylprednisolone (MPPT)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MPPT) 30 mg/kg
Trial: 2570086
Drug: Haloperidol decanoate
RxNorm normalized name: Haloperidol Decanoate
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol decanoate (1.5 cc or 75 mg)
Trial: 2570086
Drug: Fluphenazine decanoate
RxNorm normalized name: Fluphenazine Decanoate
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate (1 cc or 25 mg)
Trial: 183591
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of prednisone on alternate days
Trial: 183591
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets on alternate days
Trial: 183591
Drug: Prednisone maintenance
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone maintenance dosage after 2 years
Trial: 31116017
Drug: Audio-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Audio-based cognitive behavioral therapy
Trial: 29901860
Drug: BFF MDI
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BFF MDI 320/10 μg
Trial: 29901860
Drug: BUD/FORM DPI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUD/FORM DPI 320/9-μg delivered dose
Trial: 28598402
Drug: Carbohydrate mouth
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate mouth rinsing (CHO: 1.6 g/25 mL)
Trial: 28598402
Drug: Caffeine mouth
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine mouth rinsing (CAF: 67 mg/25 mL)
Trial: 28598402
Drug: Guarana mouth
RxNorm normalized name: GUARANA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guarana mouth rinsing (GUA: 0.4 g/25 mL)
Trial: 25740807
Drug: Large-diameter deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large-diameter deep anterior lamellar keratoplasty (L-DALK)
Trial: 10223231
Drug: 5-FU 2600
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU 2600 mg/m2 with LV 100 mg/m2 administered via a portable infusion pump over 24 hours once a week for 5 weeks
Trial: 2695558
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (vascular medications)
Trial: 343787
Drug: Vincamine containing
RxNorm normalized name: vincamine
DrugBank: Vincamine (DB13374)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vincamine containing formulation (Pervincamin forte retard or Pervincamin ampoules)
Trial: 31504690
Drug: High water
RxNorm normalized name: Dimethicone 1.5 g in 75 mL TOPICAL CREAM [SONATURAL HIGH WATER DRAW SUPER HYDRA BALM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High water intake (2.5 L/d)
Trial: 31504690
Drug: Low water
RxNorm normalized name: Acetonitrile Low Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low water intake (0.5 L/d)
Trial: 21256094
Drug: Levamisole administered
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole administered as a liniment
Trial: 16392147
Drug: 1,450-nm diode
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,450-nm diode laser treatment with cryogen cooling spray, 4, 8, or 12 J/cm2, 3 treatments at 6-week intervals
Trial: 12685794
Drug: Conical transmucosal
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conical transmucosal implants (Nobel Biocare AB), 3.75 mm large and at least 9 mm long, immediately loaded with an implant‐retained overdenture.
Trial: 12685794
Drug: Standard Brånemark
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Brånemark implants (MK II; Nobel Biocare AB), 3.75 mm large and at least 10 mm long, immediately loaded with an implant‐retained overdenture.
Trial: 9859076
Drug: Cefixime (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime (400 mg/24 h in a single daily dose for 12 days)
Trial: 9859076
Drug: Amoxicillin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (1 g/8 h per os) plus netilmicin (4 mg/kg/24 h in a single intramuscular daily dose for 5 days)
Trial: 9859076
Drug: Amoxicillin plus
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin plus netilmicin
Trial: 9859076
Drug: Cefixime and
RxNorm normalized name: cefixime and ornidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime and Amoxicillin plus netilmicin
Trial: 7631301
Drug: Hemovasal (glycosaminoglycan)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemovasal (glycosaminoglycan) administered in 3 different i.m. doses as single injections
Trial: 7631301
Drug: Hemovasal (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemovasal (300 mg daily oral dose for one week)
Trial: 752851
Drug: Vincristine, cyclophosphamide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vincristine, cyclophosphamide, methotrexate, and 5-fluorouracil after conventional curative treatment
Trial: 21336855
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (intraperitoneal cisplatin, postoperative intravenous cisplatin, 5-fluorouracil, and daily oral FU (UFT) for 12 months)
Trial: 9783935
Drug: 0.8 mg
RxNorm normalized name: biotin 0.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.8 mg tamsulosin
Trial: 2974263
Drug: procaterol 0.05
RxNorm normalized name: procaterol 0.05 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: procaterol 0.05 mg twice daily for 2 wk followed by 0.10 mg twice daily for 10 wk
Trial: 2974263
Drug: albuterol 2
RxNorm normalized name: albuterol 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albuterol 2 mg three times a day for 2 wk followed by 4 mg three times a day for 10 wk
Trial: 2974263
Drug: albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albuterol
Trial: 2974263
Drug: procaterol and
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: procaterol and albuterol
Trial: 30530121
Drug: Oral β‐blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral β‐blocker therapy
Trial: 29534639
Drug: Sunitinib as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib as an adjunct to standard therapy (leucovorin, 5-fluorouracil, and irinotecan)
Trial: 29534639
Drug: Placebo as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo as an adjunct to standard therapy (leucovorin, 5-fluorouracil, and irinotecan)
Trial: 29534639
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (leucovorin, 5-fluorouracil, and irinotecan)
Trial: 26467679
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health promotion (OHP) activities
Trial: 22057424
Drug: β-glucan-enriched beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-glucan-enriched beverage (3 g barley β-glucan)
Trial: 22057424
Drug: Fruit-based beverage
RxNorm normalized name: RESOURCE FRUIT BEVERAGE LIQUID (ORANGE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fruit-based beverage (2.5 g dietary fibre)
Trial: 17374316
Drug: Efalizumab 1
RxNorm normalized name: efalizumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efalizumab 1 mg/kg weekly for 12 weeks
Trial: 7598055
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with energy density of 1.67, 2.93, 4.18, or 6.28 kJ/g fed ad libitum three, four, or five times per day
Trial: 2220978
Drug: 200,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200,000 IU of oral vitamin A
Trial: 619324
Drug: Combination chemotherapeutic
RxNorm normalized name: ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapeutic agents (ACFUME, ACFUCY)
Trial: 30220280
Drug: Insulin caliper
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin caliper for blood glucose control
Trial: 30220280
Drug: Conventional group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional group (paper-based insulin dose modification scheme)
Trial: 27217097
Drug: High-purity plasma-derived
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-purity plasma-derived factor X concentrate (pdFX) administered preoperatively to raise FX:C to 70-90 IU dL(‐1) and postoperatively to maintain levels >50 IU dL(‐1) until no longer at risk of bleeding due to surgery.
Trial: 22112969
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2 day 1) and prednisone (5 mg orally twice daily every 21 days) plus AT-101 (40 mg twice daily on days 1-3)
Trial: 22112969
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2 day 1) and prednisone (5 mg orally twice daily every 21 days) plus placebo
Trial: 20940688
Drug: Information on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information on anxiolytic technique, local anesthesia, and treatment of perioperative pain
Trial: 17438342
Drug: Eclectic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eclectic treatment
Trial: 16678648
Drug: MAS XR
RxNorm normalized name: Mielim Y Mas
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MAS XR 10 mg/d
Trial: 16678648
Drug: MAS XR
RxNorm normalized name: Mielim Y Mas
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MAS XR 20 mg/d
Trial: 1517643
Drug: Phenytoin (PHT)
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin (PHT) 100 mg by mouth twice daily
Trial: 1517643
Drug: Buprenorphine (Bu)
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine (Bu) 0.2 mg sublingually twice daily
Trial: 1517643
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (PHT 50 mg PO + Bu 0.1 mg SL twice daily)
Trial: 6149671
Drug: Prenalterol (100‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenalterol (100‐200 mg daily)
Trial: 6149671
Drug: Intensified treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified treatment with diuretics
Trial: 6149671
Drug: Control periods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control periods / intensified conventional treatment
Trial: 30412325
Drug: Baseline viral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline viral load cutpoint of 800,000 IU/mL
Trial: 28436380
Drug: Entecavir-adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Entecavir-adefovir dipivoxil (ETV-ADV) combination therapy
Trial: 28091491
Drug: Standard pharmaceutical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pharmaceutical treatment for IBS (myotropic anti‐spasmodics and lactulose)
Trial: 22281004
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg for the first two weeks, 10 mg for the last two weeks)
Trial: 20133263
Drug: Albumin-bound paclitaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin-bound paclitaxel weekly for 12 weeks followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) every 3 weeks for 4 cycles
Trial: 18751500
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation containing 400 mg dexibuprofen
Trial: 18751500
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation containing 400 mg dexibuprofen
Trial: 10372564
Drug: Gabapentin (600,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (600, 1200, or 2400 mg/day)
Trial: 8908676
Drug: LHRH agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LHRH agonist leuprolide depot for 24 weeks
Trial: 31563241
Drug: Twice-Daily Tacrolimus
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-Daily Tacrolimus (Prograf)
Trial: 31563241
Drug: Once-Daily Tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-Daily Tacrolimus (Advagraf)
Trial: 31563241
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Twice-Daily and Once-Daily Tacrolimus)
Trial: 28420367
Drug: iFightDepression (iFD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iFightDepression (iFD) tool + Treatment as Usual (TAU)
Trial: 28420367
Drug: Internet-based psychoeducation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based psychoeducation + Treatment as Usual (TAU)
Trial: 21306473
Drug: Caudal morphine-bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal morphine-bupivacaine (100 μg·kg(‐1) morphine, mixed with 0.25% bupivacaine with 1 : 200,000 epinephrine)
Trial: 21306473
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (150 μg·kg(‐1)) with droperidol (75 μg·kg(‐1))
Trial: 21306473
Drug: Caudal morphine-bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal morphine-bupivacaine
Trial: 17881400
Drug: IVIG 150
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG 150 mg/kg on Day 1, placebo on Days 2 and 3 (Group I)
Trial: 17881400
Drug: IVIG 450
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG 450 mg/kg on Day 1, 300 mg/kg on Day 2, 150 mg/kg on Day 3 (Group II)
Trial: 17881400
Drug: IVIG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG treatment (both groups)
Trial: 11558817
Drug: latanoprost 0.005%
RxNorm normalized name: LATANOPROST 0.005% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: latanoprost 0.005% once daily plus timolol 0.5% twice daily
Trial: 11558817
Drug: dorzolamide 2%
RxNorm normalized name: Brimonidine Tartrate 0.1%, Dorzolamide 2% Ophthalmic drops, solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dorzolamide 2% twice daily plus timolol 0.5% twice daily
Trial: 9491039
Drug: Frozen solution
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frozen solution (FS)
Trial: 9491039
Drug: Conventional glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional glucose electrolyte solution (CS)
Trial: 9491039
Drug: Frozen solution
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frozen solution (FS) after crossover from CS
Trial: 9491039
Drug: Conventional glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional glucose electrolyte solution (CS) after crossover from FS
Trial: 3163133
Drug: High-dose cytotoxic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cytotoxic therapy
Trial: 31748424
Drug: Epidural anesthesia
RxNorm normalized name: Epidural Anesthesia Tray
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural anesthesia plus 7% lidocaine cream applied around the chest tube insertion site 20 min before removal (Group L)
Trial: 31748424
Drug: Epidural anesthesia
RxNorm normalized name: Epidural Anesthesia Tray
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural anesthesia plus placebo cream (Group P)
Trial: 28976835
Drug: Cryopreserved human
RxNorm normalized name: cryopreserved human liver cells
DrugBank: cryopreserved human liver cells (DB05852)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryopreserved human umbilical cord (cUC) allograft with negative pressure wound therapy (NPWT)
Trial: 25800685
Drug: Ca/Mg infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ca/Mg infusion
Trial: 19293352
Drug: Lactate (Lac)
RxNorm normalized name: lactate Topical Cream [Lac-Hydrin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactate (Lac) solution
Trial: 19293352
Drug: Lactate/bicarbonate (Lac/Bic)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactate/bicarbonate (Lac/Bic) solution
Trial: 16400650
Drug: Menatetrenone (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menatetrenone (45 mg daily)